We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
AI Tool Predicts Who Will Develop Pancreatic Cancer Based on CT Images
News

AI Tool Predicts Who Will Develop Pancreatic Cancer Based on CT Images

AI Tool Predicts Who Will Develop Pancreatic Cancer Based on CT Images
News

AI Tool Predicts Who Will Develop Pancreatic Cancer Based on CT Images

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "AI Tool Predicts Who Will Develop Pancreatic Cancer Based on CT Images"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

An artificial intelligence (AI) tool developed by Cedars-Sinai investigators accurately predicted who would develop pancreatic cancer based on what their CT scan images looked like years prior to being diagnosed with the disease. The findings, which may help prevent death through early detection of one of the most challenging cancers to treat, are published in the journal Cancer Biomarkers.


“This AI tool was able to capture and quantify very subtle, early signs of pancreatic ductal adenocarcinoma in CT scans years before occurrence of the disease. These are signs that the human eye would never be able to discern,” said Debiao Li, PhD, director of the Biomedical Imaging Research Institute, professor of Biomedical Sciences and Imaging at Cedars-Sinai, and senior and corresponding author of the study. Li is also the Karl Storz Chair in Minimally Invasive Surgery in Honor of George Berci, MD.


Pancreatic ductal adenocarcinoma is not only the most common type of pancreatic cancer, but it’s also the most deadly. Less than 10% of people diagnosed with the disease live more than five years after being diagnosed or starting treatment. But recent studies have reported that finding the cancer early can increase survival rates by as much as 50%. There currently is no easy way to find pancreatic cancer early, however.


People with this type of cancer may experience symptoms such as general abdominal pain or unexplained weight loss, but these symptoms are often ignored or overlooked as signs of the cancer since they are common in many health conditions.


“There are no unique symptoms that can provide an early diagnosis for pancreatic ductal adenocarcinoma,” said Stephen J. Pandol, MD, director of Basic and Translational Pancreas Research and program director of the Gastroenterology Fellowship Program at Cedars-Sinai, and another author of the study. “This AI tool may eventually be used to detect early disease in people undergoing CT scans for abdominal pain or other issues.”


The investigators reviewed electronic medical records to identify people who were diagnosed with the cancer within the last 15 years and who underwent CT scans six months to three years prior to their diagnosis. These CT images were considered normal at the time they were taken. The team identified 36 patients who met these criteria, the majority of whom had CT scans done in the ER because of abdominal pain.


The AI tool was trained to analyze these pre-diagnostic CT images from people with pancreatic cancer and compare them with CT images from 36 people who didn’t develop the cancer. The investigators reported that the model was 86% accurate in identifying people who would eventually be found to have pancreatic cancer and those who would not develop the cancer.


The AI model picked up on variations on the surface of the pancreas between people with cancer and healthy controls. These textural differences could be the result of molecular changes that occur during the development of pancreatic cancer.


“Our hope is this tool could catch the cancer early enough to make it possible for more people to have their tumor completely removed through surgery,” said Touseef Ahmad Qureshi, PhD, a scientist at Cedars-Sinai and first author of the study.


The investigators are currently collecting data from thousands of patients at healthcare sites throughout the U.S. to continue to study the AI tool’s prediction capability.


Reference: Qureshi TA, Gaddam S, Wachsman AM, et al. Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images. Cancer Biomark. 2022;33(2):211-217. doi: 10.3233/CBM-210273


This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Advertisement